Go Pro
→ Wall Street Preps for a 382 Trillion Dollar Financial Shift by 2027 (From Awesomely) (Ad)tc pixel Free GCAN Stock Alerts

Greater Cannabis (GCAN) Competitors

Greater Cannabis logo
$0.23 0.00 (0.00%)
As of 08/12/2026 09:31 AM Eastern
Compare

GCAN vs. SXTPW, BFRIW, CALA, CINGW, and CMRAW

Should you buy Greater Cannabis stock or one of its competitors? Greater Cannabis's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Calithera Biosciences (CALA), Cingulate (CINGW), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Greater Cannabis compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Greater Cannabis (NASDAQ:GCAN) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, risk, institutional ownership and earnings.

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Greater Cannabis N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
Greater CannabisN/AN/AN/AN/AN/A

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than Greater Cannabis. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Greater Cannabis. 60 Degrees Pharmaceuticals' average media sentiment score of 1.87 beat Greater Cannabis' score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
60 Degrees Pharmaceuticals Very Positive
Greater Cannabis Neutral

Summary

60 Degrees Pharmaceuticals beats Greater Cannabis on 3 of the 3 factors compared between the two stocks.

How does Greater Cannabis compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Greater Cannabis (NASDAQ:GCAN) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$43.20MN/AN/AN/AN/A
Greater CannabisN/AN/AN/AN/AN/A

In the previous week, Biofrontera had 3 more articles in the media than Greater Cannabis. MarketBeat recorded 3 mentions for Biofrontera and 0 mentions for Greater Cannabis. Biofrontera's average media sentiment score of 0.96 beat Greater Cannabis' score of 0.00 indicating that Biofrontera is being referred to more favorably in the media.

Company Overall Sentiment
Biofrontera Positive
Greater Cannabis Neutral

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Greater Cannabis N/A N/A N/A

Summary

Biofrontera beats Greater Cannabis on 3 of the 3 factors compared between the two stocks.

How does Greater Cannabis compare to Calithera Biosciences?

Calithera Biosciences (NASDAQ:CALA) and Greater Cannabis (NASDAQ:GCAN) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Calithera BiosciencesN/AN/A-$39.65MN/AN/A
Greater CannabisN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Calithera BiosciencesN/A N/A N/A
Greater Cannabis N/A N/A N/A

In the previous week, Calithera Biosciences' average media sentiment score of 0.00 equaled Greater Cannabis'average media sentiment score.

Company Overall Sentiment
Calithera Biosciences Neutral
Greater Cannabis Neutral

Summary

Calithera Biosciences and Greater Cannabis tied by winning 0 of the 0 factors compared between the two stocks.

How does Greater Cannabis compare to Cingulate?

Greater Cannabis (NASDAQ:GCAN) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

Company Net Margins Return on Equity Return on Assets
Greater CannabisN/A N/A N/A
Cingulate N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Greater CannabisN/AN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

In the previous week, Cingulate had 2 more articles in the media than Greater Cannabis. MarketBeat recorded 2 mentions for Cingulate and 0 mentions for Greater Cannabis. Cingulate's average media sentiment score of 1.44 beat Greater Cannabis' score of 0.00 indicating that Cingulate is being referred to more favorably in the news media.

Company Overall Sentiment
Greater Cannabis Neutral
Cingulate Positive

Summary

Cingulate beats Greater Cannabis on 2 of the 2 factors compared between the two stocks.

How does Greater Cannabis compare to Comera Life Sciences?

Greater Cannabis (NASDAQ:GCAN) and Comera Life Sciences (NASDAQ:CMRAW) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations.

In the previous week, Greater Cannabis' average media sentiment score of 0.00 equaled Comera Life Sciences'average media sentiment score.

Company Overall Sentiment
Greater Cannabis Neutral
Comera Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
Greater CannabisN/A N/A N/A
Comera Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Greater CannabisN/AN/AN/AN/AN/A
Comera Life Sciences$1.00MN/AN/AN/AN/A

Summary

Comera Life Sciences beats Greater Cannabis on 1 of the 1 factors compared between the two stocks.

Get Greater Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for GCAN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GCAN vs. The Competition

Export
MetricGreater CannabisPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$11.88B$7.07B$12.99B
Dividend YieldN/A2.70%2.58%10.72%
P/E RatioN/A783.89269.6325.21
Price / SalesN/A744.11600.52101.12
Price / CashN/A67.4570.5350.75
Price / BookN/A10.6213.176.24
Net IncomeN/A$2.77B$3.45B$347.70M
7 Day Performance-39.08%-0.12%0.74%0.87%
1 Month Performance-8.00%0.04%1.41%0.90%
1 Year PerformanceN/A161.17%67.05%20.13%

Greater Cannabis Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GCAN
Greater Cannabis
N/A$0.23
flat		N/A+114,950.0%$0.00N/AN/A1
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
+39.2%		N/A-67.6%$0.00$1.00MN/A2
BFRIW
Biofrontera
N/A$0.03
+27.6%		N/A-81.6%$0.00$43.20MN/A70
CALA
Calithera Biosciences
N/AN/AN/AN/A$0.00N/AN/A60
CINGW
Cingulate
N/A$0.01
+9.7%		N/A-87.9%$0.00N/AN/A20

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:GCAN) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
Central banks bought 710 tonnes - this fund pays monthly
Gold is hitting new highs, fueled by tariffs and record central bank demand - 710 tonnes per quarter. JPMorgan...
Investors Alley | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel